Found (943) clinical trials

If you have diabetes or heart disease, reducing health risk factors can improve your quality of life. Lowering blood cholesterol levels that are too high reduces the risk for developing heart disease and lessens the chance of heart attack, stroke or dying of coronary heart disease (CHD). A clinical research ...

You may be eligible to participate in a clinical research study of an investigational medication to lower your risk of heart attack or stroke. Qualifications for this investigational drug study include: A simple blood test called c-reactive protein may predict the future risk or heart attack and or stroke. Men ...

Doctors commonly prescribe 325 milligrams of aspirin daily for their patients to reduce the risk of suffering another heart attack or stroke. However, daily aspirin therapy may increase a person's risk for stomach ulcers. The purpose of these studies is to determine the safety and effectiveness of an investigational drug ...

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

Have you been told that you have or that you are at risk for developing Heart Disease? If you are 45 years of age or older and have high triglyceride levels, you may be eligible to participate in a clinical research study evaluating the safety and effectiveness of an investigational ...

The purpose of this study is to see if using the results of a blood test called NT-proBNP (a hormone released from the heart also known as a biomarker) can help doctors decide the best drug treatment for patients with heart failure (HF). Approximately 1,100 people will take part in ...

The primary efficacy objective is to determine whether treatment with dapagliflozin compared with placebo when added to current background therapy will result in a reduction in the incidence of the composite endpoint of cardiovascular death, myocardial infarction (MI), or ischemic stroke in patients with type 2 diabetes mellitus (T2DM) with ...

Do you need help for heart disease, heart conditions, heart attack or stroke? Meridien Research is seeking research volunteers for a clinical study of heart disease, heart conditions, heart attack or stroke.

To understand the long-term outcomes of patients with mild and rapidly improving stroke symptoms, this prospective observational study will leverage the current information in the Get With The Guidelines-Stroke registry and collect 90-day outcomes. A total of 2650 patients with mild and/or rapidly improving stroke symptoms will be enrolled in ...